Skip to main content
Premium Trial:

Request an Annual Quote

DNA Sciences Announces Management Changes

NEW YORK, Feb 7 – Population genetics company DNA Sciences said Wednesday that its chief operating officer and head of technology development, Greg Went, resigned.

The Fremont, Calif.-based company said it would not replace Went, who left to “pursue other interests.”

DNA Sciences also announced that it appointed Christopher Burrow to head the company’s clinical research efforts. He will be involved with the company's genetic research and product development programs. He will also work with outside scientific collaborators and medical groups.

Burrow will report to Raymond White, DNA Sciences' chief scientific officer.

DNA Sciences, which recently filed for an IPO, studies the role genes play in diseases such as cancer, asthma, and diabetes. It is also planning to commercialize diagnostic tests.  

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.